Roy Anderson, Group VP of Marketing Strategy and Commercial Development, Horizon Pharma plc
Bruce Bloom, DDS, JD, President and Chief Science Officer, Cures Within Reach
Gauthier Bouche, MD, Medical Director, Anticancer Fund
Christine Colvis, Ph.D., Director, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS), NIH
Daniel M. Czyz, Ph.D., Postdoctoral Scholar/Crosson Lab, Department of Biochemistry & Molecular Biology, University of Chicago
Sivanesan Dakshanamurthy, Ph.D., Associate Professor of Oncology, Clinical & Experimental Therapeutics Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
Chris Gibson, Ph.D, MD, Chief Executive Officer, Recursion Pharmaceuticals
Tim Guilliams, Ph.D., Chief Executive, Healx
Raul Insa, MD, Ph.D., MBA, Founder and CEO, SOM Biotech
Alexander Ivliev, Ph.D., Senior Scientist, Thomson Reuters Life Sciences
Hermann Mucke, Ph.D., Chief Executive, H.M. Pharma Consultancy
Stephen Naylor, Ph.D., Chairman & CEO, MaiHealth Inc.
Aris Persidis, Ph.D., President, Biovista
James Pickett, Ph.D., Head of Research, Alzheimer's Society
Tomasz Sablinski, MD, Ph.D., Chief Executive Officer, Transparency Life Sciences
Mohamed Seleem, Ph.D., Assistant Professor of Microbiology, Department of Comparative Pathobiology, Purdue University School of Veterinary Medicine
E. Mitchell Seymour, Ph.D., RAC., Director, Founder, R&D Advisors LLC, Faculty, University of Michigan Institute for Clinical and Health Research
Craig Webb, Ph.D., Chief Scientific Officer, NuMedii
Scott Weir, PharmD, Ph.D., Director, Institute for Advancing Medical Innovation, Associate Director, Translational Research, University of Kansas Cancer Center, Professor, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center
Dr. Richard Wyse, Director of Research and Development, The Cure Parkinson's Trust